NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $212,920 | -12.7% | 2,110 | -20.4% | 0.04% | -10.4% |
| Q1 2023 | $243,892 | -4.5% | 2,651 | -5.8% | 0.05% | -9.4% |
| Q4 2022 | $255,286 | +22.1% | 2,814 | +2.6% | 0.05% | +6.0% |
| Q3 2022 | $209,000 | -12.2% | 2,744 | -2.5% | 0.05% | -5.7% |
| Q2 2022 | $238,000 | -2.9% | 2,814 | +0.7% | 0.05% | +10.4% |
| Q1 2022 | $245,000 | +5.2% | 2,795 | +4.8% | 0.05% | +2.1% |
| Q4 2021 | $233,000 | +6.9% | 2,666 | 0.0% | 0.05% | -7.8% |
| Q3 2021 | $218,000 | -10.3% | 2,666 | 0.0% | 0.05% | -8.9% |
| Q2 2021 | $243,000 | +17.4% | 2,666 | +10.3% | 0.06% | -5.1% |
| Q1 2021 | $207,000 | -46.8% | 2,416 | -41.4% | 0.06% | -50.4% |
| Q4 2020 | $389,000 | +40.4% | 4,122 | +29.9% | 0.12% | +7.2% |
| Q2 2020 | $277,000 | +5.7% | 3,172 | 0.0% | 0.11% | -8.3% |
| Q1 2020 | $262,000 | +23.0% | 3,172 | +46.4% | 0.12% | -49.6% |
| Q2 2015 | $213,000 | +0.5% | 2,166 | +0.7% | 0.24% | +44.6% |
| Q1 2015 | $212,000 | +5.0% | 2,151 | 0.0% | 0.17% | -16.2% |
| Q3 2014 | $202,000 | – | 2,151 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |